Detalhe da pesquisa
1.
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol
; 26(8): 1685-91, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25935792
2.
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Ann Oncol
; 26(2): 313-20, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403582
3.
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer.
Br J Cancer
; 111(5): 837-42, 2014 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003667
4.
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
Ann Oncol
; 25(2): 366-71, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24347519
5.
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol
; 25(2): 339-45, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24347518
6.
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Br J Cancer
; 109(3): 589-96, 2013 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23868011
7.
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer
; 108(7): 1408-14, 2013 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23511562
8.
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
Br J Cancer
; 109(12): 2959-64, 2013 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24157828
9.
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Ann Oncol
; 24(3): 640-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23035151
10.
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.
Ann Oncol
; 24(5): 1203-11, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23293111
11.
Long-term outcomes after endothoracic sympathetic block at the T4 ganglion for upper limb hyperhidrosis.
Br J Surg
; 100(11): 1471-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24037567
12.
Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study.
Breast Cancer Res Treat
; 127(1): 121-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20848185
13.
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
Ann Oncol
; 21(5): 955-60, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19940005
14.
Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma.
Br J Surg
; 96(8): 919-25, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19591163
15.
Recent developments in breast-conserving surgery for breast cancer patients.
Langenbecks Arch Surg
; 394(4): 591-609, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18781322
16.
Breast cancer chemoprevention - a vision not yet realized.
Eur J Cancer Care (Engl)
; 18(5): 438-46, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19686352
17.
New epidemiological aspects of patients with severe hyperhidrosis presenting for sympathetic surgery.
J Eur Acad Dermatol Venereol
; 23(6): 651-5, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19250333
18.
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Breast
; 46: 101-107, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132475
19.
Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.
Lancet
; 369(9574): 1711-23, 2007 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-17512856
20.
Guidelines on the standards for the training of specialised health professionals dealing with breast cancer.
Eur J Cancer
; 43(4): 660-75, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17276672